Literature DB >> 5471444

Gamma-hydroxybutyrate-induced increase in brain dopamine: localization by fluorescence microscopy.

G K Aghajanian, R H Roth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5471444

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  21 in total

1.  Dopaminergic inhibition of striatal cholinergic neurons: synergistic blocking action of gamma-butyrolactone and neuroleptic drugs.

Authors:  H Stadler; K G Lloyd; G Bartholini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

2.  Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

Authors:  J W Kebabian; G L Petzold; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

3.  Increase in brain dopamine after axotomy or treatment with gammahydroxybutyric acid due to elimination of the nerve impulse flow.

Authors:  G Stock; T Magnusson; N E Andén
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

4.  Gamma-butyrolactone: an anesthetic with hyperthermic action in the rat.

Authors:  A A Borbély; J P Huston
Journal:  Experientia       Date:  1972-12-15

Review 5.  gamma-Hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness.

Authors:  Daniel Pardi; Jed Black
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

6.  Suppression of ethanol-induced locomotor stimulation by GABA-like drugs.

Authors:  J Cott; A Carlsson; J Engel; M Lindqvist
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-12       Impact factor: 3.000

7.  Dopaminergic neurons: reversal of effects elicited by gamma-butyrolactone by stimulation of the nigro-neostriatal pathway.

Authors:  L C Murrin; R H Roth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-10       Impact factor: 3.000

8.  Pharmacological evidence for a selective antidopaminergic action of gamma-hydroxybutyric acid.

Authors:  K Menon; D Bieger; O Hornykiewicz
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

9.  Differential drug effects on dopamine concentrations and rates of turnover in the median eminence, olfactory tubercle and corpus striatum.

Authors:  G A Gudelsky; E K Moore
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

10.  Chronic L-dopa treatment of rats and mice does not change the sensitivity of post-synaptic dopamine receptors.

Authors:  D M Jackson; O F Jenkins; R Malor; M J Christie; P Gregory
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-12       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.